West Pharmaceutical Services   Report issue

For profit Phase 1
Founded: Exton PA United States (1923)
Status: No NME R&D (1923)

Organization Overview

First Clinical Trial
2005
NCT00444522
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

West Pharmaceutical Services, GFI Research Center, Evansville, IN 47714

Active Ingredients

Drugs in Phase 1 Trials (2)

alprazolam (1 trial)

loxapine (loxitane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Schizophrenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2